Results 231 to 240 of about 205,750 (304)

Proliferative Tumor States and Immunogenic Ecosystems Predict Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer. [PDF]

Biomedicines
Teng Y, Li H, Cheng L, Jiang Y, Jiang H, Liu Y.   +5 more
europepmc   +1 more source

Five Advances in the Last 50 Years: Liver Malignancies

World Journal of Surgery, EarlyView.
Alex B. Blair, Timothy M. Pawlik
wiley   +1 more source

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski, Rachel Dear, Sanjeev Kumar, Hilary Martin, Dhanusha Sabanathan, Stephen J. Luen, Belinda Yeo   +6 more
wiley   +1 more source

Novel hypoxia-immune biomarkers predict response to neoadjuvant chemotherapy in patients with laryngo-hypopharyngeal cancer. [PDF]

Eur J Med Res
Wang L, Li H, Feng L, Fang J, Wang R.
europepmc   +1 more source

What Is the Evidence Base Regarding Early Onset Colorectal Cancer in Australia and New Zealand? A Scoping Review

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background Early onset colorectal cancer (EoCRC), commonly defined as colorectal cancer diagnosed in people under 50 years of age, is increasing in incidence in Australia and New Zealand. The underlying cause of this remains unclear, despite its growing public health importance.
Tiffany J. Cherry, Dilshan Udayasiri, Ian P. Hayes   +2 more
wiley   +1 more source

Clinical Implications of Nutritional Intake in Patients With Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy and Neoadjuvant Chemotherapy. [PDF]

Cancer Med
Tamai Y, Yamada A, Katada C, Tamaoki M, Nomura M, Yokoyama A, Inoo H, Fujii K, Sakanaka K, Tsunoda S, Ohashi S, Nishikawa Y, Inoue M, Obama K, Mizowaki T, Muto M.   +15 more
europepmc   +1 more source

Axillary Lymph Node Yield Following Axillary Dissection in Biopsy‐Proven Node‐Positive Breast Cancer: Neoadjuvant Systemic Therapy Versus Primary Surgery

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background Neoadjuvant systemic therapy (NAST) induces morphological changes within the axilla; however, its impact on lymph node yield (LNY) following axillary lymph node dissection (ALND) is less clear. Methods A retrospective cohort study was performed including female patients who underwent ALND for biopsy‐proven node‐positive breast ...
Zachary Pluim, Roy Huynh, Steven Paredes, Hema Mahajan, Nicholas Ngui   +4 more
wiley   +1 more source

Ultrasound and immunohistochemical predictors of neoadjuvant chemotherapy response in breast cancer. [PDF]

Transl Cancer Res
Ma Y, Zhu Y, Zhu J, Nie F.
europepmc   +1 more source

Two Decades of Multimodal Management of Colorectal Liver Metastases With Long‐Term Outcomes

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background The management of patients with colorectal liver metastases (CRLM) is complex and requires a tailored approach based on disease extent, patient age, and comorbidities. Given the heterogeneity in presentation and evolving treatment algorithms, prognostic factors for long‐term survival following liver resection are contested.
Ali Mohtashami, Prajwol Shrestha, Sharon Chen, Jean‐Luc Vrisakis, Nazim Bhimani, Nick Pavlakis, Stephen J. Clarke, Connie I. Diakos, Matthew Wong, Thomas J. Hugh   +9 more
wiley   +1 more source

MRI based unsuperviced clustering on MIBC reveals intratumor heterogeneity phenotypes and neoadjuvant chemotherapy efficacy. [PDF]

Cancer Imaging
Zhang Y, Cai L, Chen Y, Bai R, Wang C, Tan Z, Chen C, Liu X, Liang B, Jiang M, Wang G, Shao Q, Jiang X, Bao M, Yu H, Cao Q, Yang X, Lu Q.   +17 more
europepmc   +1 more source